Cargando…

A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression

Accurately predicting the survival prospects of patients suffering from pancreatic adenocarcinoma (PAAD) is challenging. In this study, we analyzed RNA matrices of 182 subjects with PAAD based on public datasets obtained from The Cancer Genome Atlas (TCGA) as training datasets and those of 63 subjec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Lin-ying, Huang, Han-ying, Fang, Tian, Liang, Jia-ying, Hao, Yu-lei, Zhang, Xue-jiao, Xie, Yi-xin, Wang, Chang, Tan, Ye-hui, Zeng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158121/ https://www.ncbi.nlm.nih.gov/pubmed/35664305 http://dx.doi.org/10.3389/fgene.2022.804190

Ejemplares similares

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
por: Song, Wenjing, et al.
Publicado: (2021)

Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes
por: Xie, Haoran, et al.
Publicado: (2022)

Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
por: Mishra, Nitish Kumar, et al.
Publicado: (2019)

Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma
por: Zhang, Zilong, et al.
Publicado: (2022)

Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA
por: Huang, Liya, et al.
Publicado: (2022)

Development and validation of a prognostic prediction model for iron metabolism-related genes in patients with pancreatic adenocarcinoma
por: Wei, Wenhan, et al.
Publicado: (2023)

Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics
por: Guo, Kai, et al.
Publicado: (2023)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

Combining Single-Cell and Transcriptomic Data Revealed the Prognostic Significance of Glycolysis in Pancreatic Cancer
por: Chen, Liang, et al.
Publicado: (2022)

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
por: Shi, Cheng, et al.
Publicado: (2019)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma
por: Bai, Kaisong, et al.
Publicado: (2021)

Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases
por: Wen, Xin, et al.
Publicado: (2021)

Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer
por: Xie, Lin-Ying, et al.
Publicado: (2023)

Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
por: Zhu, Zhi-gang, et al.
Publicado: (2022)

Prognostic Model of Eleven Genes Based on the Immune Microenvironment in Patients With Thymoma
por: Yang, Ying, et al.
Publicado: (2022)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications
por: Wen, Heng, et al.
Publicado: (2022)

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases
por: Mao, Miaobin, et al.
Publicado: (2021)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
por: Liu, Xia, et al.
Publicado: (2022)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis
por: Tang, Hao-dong, et al.
Publicado: (2022)

Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes
por: Zhang, Chong, et al.
Publicado: (2021)

Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes
por: Su, Lili, et al.
Publicado: (2022)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma
por: Hou, Shaohui, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma
por: Wang, Su, et al.
Publicado: (2022)

Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
por: Li, Xiaomin, et al.
Publicado: (2021)

The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD)
por: Xin, Shiyong, et al.
Publicado: (2022)

Gene set variation analysis-based aging and senescence score as a prognostic indicator and therapeutic guide in lung adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2023)

Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing
por: Chung, An-Ko, et al.
Publicado: (2023)

Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma
por: Xiong, Ronghong, et al.
Publicado: (2022)

Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
por: Li, Xiaomin, et al.
Publicado: (2022)

Corrigendum: Prognostic values and clinical significance of S100 family member’s individualized mRNA expression in pancreatic adenocarcinoma
por: Li, Xiaomin, et al.
Publicado: (2022)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma
por: Ge, Jiachen, et al.
Publicado: (2022)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Analysis of the Prognostic Significance and Immune Infiltration of the Amino Acid Metabolism-Related Genes in Colon Adenocarcinoma
por: Wang, Zhenling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1c5l8ocreqnqba8uig1v5mkusg